Inagene Logo.jpg
September’s International Pain Awareness Month marks critical moment to leverage more effective methods of treating chronic pain
26 août 2021 06h00 HE | Inagene Diagnostics Inc.
TORONTO, Aug. 26, 2021 (GLOBE NEWSWIRE) -- September marks Canada’s most important International Pain Awareness Month yet. The stressors brought on by the COVID-19 pandemic have manifested as new...
Inagene Logo.jpg
Inagene and Aspiria team up to improve mental health care for post-secondary students
16 août 2021 06h00 HE | Inagene Diagnostics Inc.
TORONTO, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Canadian pharmacogenetic (PGx) testing provider, Inagene Diagnostics Inc., has partnered with Student Assistance Program provider Aspiria Corp., a CloudMD...
logo long.jpg
Global Gene Panel Market to Surpass US$ 29,975.8 Million by 2028, Says Coherent Market Insights (CMI)
02 août 2021 09h00 HE | CMI
SEATTLE, Aug. 02, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global gene panel market is estimated to be valued at US$ 22,044.7 million in 2021 and is expected to exhibit a...
Inagene Logo.jpg
Canada’s surgery backlog could lead to wave of new chronic pain and opioid dependencies
21 juil. 2021 06h00 HE | Inagene Diagnostics Inc.
TORONTO, July 21, 2021 (GLOBE NEWSWIRE) -- As Canada’s vaccination rates climb and hospitals begin to tackle the mountain of postponed surgeries due to the pandemic, we are facing an echo epidemic...
22157.jpg
US & EU Direct-to-consumer Genetic Testing Market Report 2021
09 juil. 2021 08h08 HE | Research and Markets
Dublin, July 09, 2021 (GLOBE NEWSWIRE) -- The "US & EU Direct-to-consumer Genetic Testing Market, Key Trends & Growth Opportunities" report has been added to ResearchAndMarkets.com's...
Inagene Logo.jpg
Canadians living with mental health conditions stand to save over $57 billion with use of pharmacogenetic testing
08 juin 2021 07h00 HE | Inagene Diagnostics Inc.
TORONTO, June 08, 2021 (GLOBE NEWSWIRE) -- Inagene Diagnostic Inc., a Canadian pharmacogenetic testing company, and Calian Group Ltd., one of Canada's largest national health services organizations,...
22157.jpg
Worldwide Genomics in Cancer Care Industry to 2026 - Growing Burden of Cancer is Driving Growth
24 mars 2021 05h53 HE | Research and Markets
Dublin, March 24, 2021 (GLOBE NEWSWIRE) -- The "Genomics in Cancer Care Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's...
Inagene Logo.jpg
Canadian company Inagene Diagnostics launches “the other test” you need to take to protect your health in case of COVID
17 déc. 2020 09h05 HE | Inagene Diagnostics Inc.
TORONTO, Dec. 17, 2020 (GLOBE NEWSWIRE) -- As we head into the winter months, Canadians are doing everything they can protect themselves from the risk of getting sick. It turns out that if you DO...
logo.jpg
LADAVRU® NEWS “HOVERINK BIOTECHNOLOGIES SEEKS COMMERCIAL PARTNERING OPPORTUNITIES IN ONCOLOGY SUPPORTIVE THERAPIES AND SEEKS A COMMERCIALIZATION AGREEMENT FOR ITS INVESTIGATIONAL DRUG LADAVRU®”
05 juil. 2018 19h20 HE | Hoverink Biotechnologies, Inc
LOS ANGELES, CA, July 05, 2018 (GLOBE NEWSWIRE) -- HOVERINK BIOTECHNOLOGIES, seeks to enter into a licensing agreement for the exclusive rights to commercialize LADAVRU(TM) (Dronabinol for...
ARCA Logo - JPEG.jpg
ARCA biopharma Announces GENETIC-AF Data and Safety Monitoring Board Recommendation to Complete Phase 2B GENETIC-AF Clinical Trial Based on Efficacy and Safety Data in Phase 2B Interim Analysis
09 août 2017 16h30 HE | ARCA Biopharma, Inc.
ARCA Estimates Reporting Top-line Phase 2B Data in the First Quarter of 2018Gencaro Development Program Has Been Granted Fast Track Designation by U.S. FDA WESTMINSTER, Colo., Aug. 09, 2017 (GLOBE...